Allograft
-
Biologics
First Patient Treated with OssiGraft™
SAN FRANCISCO, December 14, 2023–(BUSINESS WIRE)–Ossium Health announced today that the first patient has been treated with its newly released…
Read More » -
Regulatory
AlloSource Receives FDA 510(k) Clearance For AceConnex™ Pre-Sutured Fascia For Hip Labral Reconstruction And Augmentation
First pre-sutured fascia allograft designed for hip arthroscopists to help increase surgeon efficiency and reduce operating room time CENTENNIAL, Colo., July…
Read More » -
Biologics
Study on Prochondrix Osteochondral Allograft Published in the Journal of Orthopaedic Surgery Demonstrates Encouraging Outcomes when Used on Isolated Articular Cartilage Defects
CENTENNIAL, Colo., June 29, 2023 /PRNewswire/ — AlloSource®, a leading innovator and manufacturer of cartilage for joint preservation, today announced the Journal of Orthopaedic…
Read More » -
Biologics
MTF Biologics Unveils New Tissue Form: AlloPatch® Pliable Meshed – Acellular Human Reticular Dermal Allograft
Innovative allograft offers new treatment option for diabetic foot ulcers and venous leg ulcers EDISON, N.J., April 17, 2023–(BUSINESS WIRE) —MTF…
Read More » -
Biologics
Geistlich announces the dramatic expansion of their allograft portfolio – vallos® sets the pace for regeneration
PRINCETON, N.J., March 16, 2023 /PRNewswire/ — Geistlich Pharma North America Inc. is pleased to introduce a growing variety of vallos® allograft configurations…
Read More » -
Extremities
UAT Group Subsidiary, Ossifix Orthopedics Begins Comparative Study
Tampa, FL, Jan. 20, 2023 (GLOBE NEWSWIRE) — Umbra Applied Technologies Group, Inc. (OTC Pink: UATG) (UAT Group) announce today…
Read More » -
Biologics
ALLOSOURCE®Announces New Micro Fibers Demineralized Bone Allograft
AlloFuse® Micro Fibers are the latest addition to the company’s AlloFuse line of Fibers and Fiber Boat products, expanding its…
Read More » -
Biologics
Isto Biologics Launches Influx™ Fibrant, a New Line of Advanced Allograft
HOPKINTON, Mass., June 22, 2022 (Newswire.com) – Isto Biologics, a leader in surgical-based, orthobiologic regeneration technologies and cell-based therapies, announced today the…
Read More » -
Biologics
Allosource’s Cartilage Allograft Expertise to be Featured at the International Cartilage Regeneration & Joint Preservation Society Annual Meeting
CENTENNIAL, Colo., April 5, 2022 /PRNewswire/ — AlloSource®, one of the largest allograft providers creating innovative cellular and tissue allografts to help surgeons…
Read More » -
Extremities
UAT Group Subsidiary, Ossifix Orthopedics, Begins Production of Fixation Pin, Significant Sales Expected
Tampa, FL, Feb. 14, 2022 (GLOBE NEWSWIRE) — Umbra Applied Technologies Group, Inc (OTC Pink: UATG) (UAT Group), announced today…
Read More » -
Biologics
MTF Biologics Awards More Than $1 Million in 2021 Research Grants to Support Allograft Research
Non-profit organization now accepting applications for 2022 grants to accelerate innovation in tissue transplantation February 9, 2022 EDISON, N.J.–(BUSINESS WIRE)–MTF…
Read More » -
Biologics
AlloSource Launches Allomend Extra-large Acellular Dermal Matrix
New dermal graft has the largest footprint within the AlloMend product line to support demanding soft tissue applications in plastic…
Read More » -
Biologics
AlloSource Launches AlloMend Ultra-Thick Acellular Dermal Matrix
New allograft is the thickest in the AlloMend product line to support demanding soft tissue applications CENTENNIAL, Colo., Aug. 11, 2021 /PRNewswire/…
Read More » -
Biologics
Bioventus Launches OSTEOAMP® SELECT Flowable Nationwide
DURHAM, N.C., July 13, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
Read More » -
Biologics
Kolosis BIO and MTF Biologics Announce Launch of Kore Fiber™
February 17, 2021 SALT LAKE CITY–(BUSINESS WIRE)–Kolosis BIO, LLC (Kolosis) announced today, in collaboration with MTF Biologics (MTF), the market…
Read More »